informations à fournir par le fabricant. STANDARD. ISO. Second edition . Reference number. ISO (E). Provläsningsexemplar. ISO Implants for Surgery – Active Implantable Medical Devices – Part 1: General Requirements for Safety, Marking and for Information to be Provided. It is most important that the objectives and potential uses of an. AAMI product standard or recommended practice are clearly understood. The objectives of.

| Author: | Fauzilkree Kazikus |
| Country: | Brunei Darussalam |
| Language: | English (Spanish) |
| Genre: | Relationship |
| Published (Last): | 28 September 2013 |
| Pages: | 292 |
| PDF File Size: | 11.18 Mb |
| ePub File Size: | 14.31 Mb |
| ISBN: | 333-4-71475-659-8 |
| Downloads: | 36836 |
| Price: | Free* [*Free Regsitration Required] |
| Uploader: | Tojakasa |
The appropriateness of animal models chosen should be explained and justified. For example, high voltage defibrillation leads remaining unchanged except for modifications to the lead connector may require a post-market clinical study, whereas changes to lead design that result in new therapeutic capabilities may require premarket clinical studies.
Guidance Document – Medical Device Applications for Implantable Cardiac Leads –
oso Pacing lead impedances should be measured. It has a spelling mistake. My Service Canada Account. Nanotube Biosensors for Implantable Sensing. Medical electrical equipment – Part Distal subassemblies containing the drug eluting component should be immersed in an appropriate physiologic, or non-physiologic, solution and analyzed at periodic intervals.
Ensure that the anchoring sleeves, provided premounted or as iwo, securely attach the lead when used according to the instructions for use. An alternative approach may be used if such approach satisfies the requirements of the Regulations, and should be discussed with the Medical Devices Bureau prior to filing an application.
The testing results should be reported in a statistically meaningful format [for example e.
Guidance Document – Medical Device Applications for Implantable Cardiac Leads
The following information is to be provided in an application for an investigational testing authorization, a device licence, or a licence amendment for implantable cardiac leads.
Document s cited in this standard. Cardiac rhythm management devices — Symbols to be used with cardiac rhythm management device labels, and information to be supplied — General requirements. Cardiovascular implants – Cardiac valve prostheses – Part 2: Certification of persons Do recognize your skills, register online to become certified. The YouTube for Healthcare.
Non-active surgical implants – General requirements – Implants chirurgicaux non actifs.
Lists of National Standards
ISO Clinical investigation of medical devices for human subjects – Good clinical practice. The pulse generator consists of a battery and electronic circuitry controlled by firmware. Bench testing should verify that the lead meets acceptable electrical and mechanical specifications and that the performance and integrity of the lead remains 147088-1 after storage, handling, transport, repeated sterilization and shelf life aging.

Defibrillation thresholds and lead impedances should be measured if the device is designed for cardioversion or defibrillation. This standard specifies requirements applicable to AIMDs intended to treat hearing impairment via electrical stimulation of the auditory pathways, also known as cochlear implant systems.
Active Implantable Medical Device Testing: What You Need to Know
Software for Medical Devices: Note that the fatigue testing referenced above may not sufficiently represent worst-case fatigue scenarios. Implants for surgery — Active implantable medical devices — Part 4: It is intended to supplement the guidance available on general application processes iwo procedures for Class IV and other medical devices see Bibliography.
If it is possible that test outcomes will be affected by sterilization and physiologic conditions, test leads should be conditioned prior to testing by exposure to the maximum number of allowable sterilization cycles and to simulated physiological conditions, e. The manufacturer should report lead handling characteristics, procedural success and user observations with regard to the implantation procedure 1408-1 animals.
Testing should be carried out in accordance with the methods and test flex fixtures described and illustrated in Section Additive Manufacturing in Medtech Deciphering Dosage: Although the canine model is frequently used to evaluate pacemaker leads, the choice of animal models is the responsibility of the manufacturer. The requirements of Parts listed above supplement or modify those of Part 1. Guidance documents are administrative instruments not having force of law and, as such, allow for flexibility in approach.
Reporting oso clinical performance of populations of pulse generators or leads SFDA. Alternate approaches to the principles and practices described in this document may be acceptable provided they are supported by adequate justification. Drug Identification and Quantification: May Number of pages: Securing data from a prototype device can present challenges for medical device manufacturers.
Composite Lead Tensile Strength: Long-term studies may be required to assess the durability of new insulation and other materials. The testing should be repeated for each shock configuration. Testing should use fully assembled leads for a range of pulse scenarios varying amplitudes and durations.

It is possible that additional testing may be required based on the specific nature of the lead. This portion of the standard covers specific requirements for cardiac pacemakers. B Lead Connector Testing.
Where some leakage is isl, testing should demonstrate that device function and accessory compatibility such as use of guidewire or stylet in the lumen is not iwo. Other useful information in this regard can be obtained in the following: This section covers the requirements for implantable neurostimulators, to provide basic assurance of safety for both patients and users.

